Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Melissa S. Putman"'
Autor:
Kevin J. Scully, Laura Truex, Alina Brennan, Robert Fowler, Gregory S. Sawicki, Ahmet Uluer, David S. Ludwig, Cara B. Ebbeling, Leah Langlais, Angela Dziok, Steven D. Freedman, Melissa S. Putman
Publikováno v:
Frontiers in Nutrition, Vol 11 (2024)
IntroductionTo achieve and maintain adequate weight, people with cystic fibrosis (CF) May often consume energy-dense, nutrient-poor foods high in added sugars and refined carbohydrates; however, little is known about the glycemic and metabolic effect
Externí odkaz:
https://doaj.org/article/c18e61d771ab48c9a816e5b30dba9937
Autor:
Kevin J. Scully, Laura Brenner, Kimberly Martin, Melanie Ruazol, Gregory S. Sawicki, Ahmet Uluer, Isabel Neuringer, Lael M. Yonker, Leonard Sicilian, Melissa S. Putman
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
IntroductionsCystic fibrosis-related diabetes (CFRD) is associated with pulmonary decline, compromised nutritional status, and earlier mortality. Onset is often insidious, so screening for early detection of glycemic abnormalities is important. Conti
Externí odkaz:
https://doaj.org/article/3ca9ccea3c3744a4ab80d058eb77dea9
Autor:
Krista Viau, Leslie Martell, Ann Wessel, Fran Rohr, Suzanne Hollander, Melissa S. Putman, Stephanie Sacharow
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 37, Iss , Pp 101015- (2023)
Background: Pegvaliase has allowed many adults with phenylketonuria (PKU) to achieve acceptable blood Phe control while eating an unrestricted diet. However, little is known about potential differences in nutritional status and eating behaviors after
Externí odkaz:
https://doaj.org/article/df2886244018446aa6e54903221a3875
Autor:
Zahrae Sandouk, Noura Nachawi, Richard Simon, Jennifer Wyckoff, Melissa S. Putman, Sarah Kiel, Sarah Soltman, Antoinette Moran, Amir Moheet
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 30, Iss , Pp 100308- (2022)
Progressive obstructive pulmonary disease is the primary life-shortening complication in people with Cystic Fibrosis (CF); improvement in life expectancy has led to increased prevalence of non-pulmonary complications. Patients with CF are considered
Externí odkaz:
https://doaj.org/article/ad86e030370749dd8e7341a0a9dba094
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 27, Iss , Pp 100282- (2022)
There have been tremendous advances in diabetes technology in the last decade. Continuous glucose monitors (CGM), insulin pumps, and automated insulin delivery (AID) systems aim to improve glycemic control while simultaneously decreasing the burden o
Externí odkaz:
https://doaj.org/article/caabf2f22dcb4b55a33f73d3b4b528a6
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 27, Iss , Pp 100289- (2022)
As cystic fibrosis transmembrane regulator (CFTR) modulator therapies offer greater longevity and improved health quality, women living with cystic fibrosis (CF) are increasingly pursuing pregnancy. Maternal risks for pregnant women with CF largely d
Externí odkaz:
https://doaj.org/article/588a1ccbf35d441a80d75909dd23e1bb
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 20, Iss , Pp 100223- (2020)
Objective: The purpose of this study was to determine whether estrogen supplementation primarily from oral contraceptive pills compared to no estrogen supplementation is associated with differences in mean bone mineral density (BMD) measured by DXA i
Externí odkaz:
https://doaj.org/article/7e11b4cebb2443f68c8489c527766c32
Publikováno v:
Case Reports in Endocrinology, Vol 2017 (2017)
Both cystic fibrosis (CF) and celiac disease can cause low bone mineral density (BMD) and fractures. Celiac disease may occur at a higher frequency in patients with CF than the general population, and symptoms of these conditions may overlap. We repo
Externí odkaz:
https://doaj.org/article/5f571a88d9304777a00a8d50b87c0d66
Autor:
Melissa S. Putman, Andrew W. Norris, Rebecca L. Hull, Michael R. Rickels, Lori Sussel, Scott M. Blackman, Christine L. Chan, Katie Larson Ode, Tanicia Daley, Arlene A. Stecenko, Antoinette Moran, Meagan J. Helmick, Sharon Cray, Jessica A. Alvarez, Virginia A. Stallings, Katherine L. Tuggle, John P. Clancy, Thomas L. Eggerman, John F. Engelhardt, Andrea Kelly
Publikováno v:
Diabetes. 72:677-689
Cystic fibrosis (CF) is a recessive disorder arising from mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein. CFTR is expressed in numerous tissues, with high expression in the airways, small and lar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb55f5e1de29e45a35794f2f19379ee
https://doi.org/10.2337/db22-0949
https://doi.org/10.2337/db22-0949
Publikováno v:
Diabetes Technol Ther
BACKGROUND: Cystic fibrosis-related diabetes (CFRD) is associated with pulmonary decline, compromised nutritional status, and earlier mortality. Although diabetes technology is increasingly being used in individuals with CFRD, there is a paucity of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da966831333203e1deda632766b27b5
https://doi.org/10.1089/dia.2021.0354
https://doi.org/10.1089/dia.2021.0354